Astera Labs, Inc.
Business
Astera Labs designs and sells semiconductor-based connectivity solutions purpose-built for cloud and AI infrastructure, addressing data, network, and memory bottlenecks in hyperscaler and system OEM deployments. The company's Intelligent Connectivity Platform comprises high-speed mixed-signal ICs, boards, and modules (Aries retimers and cable modules, Taurus Ethernet modules, Leo CXL memory controllers, Scorpio fabric switches) integrated with COSMOS, an embedded software suite for configuration, management, monitoring, and optimization. Products are sold directly to hyperscalers, AI accelerator vendors, and OEMs, as well as through distributors primarily in North America and Asia, with systems deployed globally across data centers.
Summary from 10-K filed 2026-02-20
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 |
|---|---|---|---|---|---|
| Revenue | 853 | 396 | 116 | 80 | |
| Cost of revenue | 207 | 94 | 36 | 21 | |
| Gross profit | 645 | 303 | 80 | 59 | |
| Research and development | 304 | 201 | 73 | 74 | |
| Sales and marketing | 80 | 124 | 20 | 24 | |
| General and administrative | 88 | 94 | 16 | 21 | |
| Total operating expenses | 472 | 419 | 109 | 119 | |
| Operating income (loss) | 173 | −116 | −29 | −60 | |
| Interest income | 45 | 34 | 7 | 3 | |
| Income (loss) before income taxes | 218 | −82 | −23 | −58 | |
| Income tax (benefit) provision | −981,000 | 2 | 3 | 764,000 | |
| Net income (loss) | 219 | −83 | −26 | −58 | |
| Basic (in dollars per share) | 1.32 | −0.64 | −0.71 | −1.71 | |
| Diluted (in dollars per share) | 1.22 | −0.64 | −0.71 | −1.71 | |
| Basic (in shares) | 166 | 131 | 37 | 34 | |
| Diluted (in shares) | 180 | 131 | 37 | 34 | |
| Unrealized gain on marketable securities, net of taxes | 4 | 167,000 | 488,000 | −229,000 | |
| Total comprehensive income (loss) | 223 | −83 | −26 | −59 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 168 | 80 | 45 | — | — | |
| Marketable securities | 1,021 | 835 | 104 | — | — | |
| Accounts receivable, net | 83 | 39 | 8 | — | — | |
| Inventory | 59 | 43 | 24 | — | — | |
| Prepaid expenses and other current assets | 31 | 17 | 4 | — | — | |
| Total current assets | 1,362 | 1,013 | 186 | — | — | |
| Property and equipment, net | 92 | 36 | 5 | — | — | |
| Other assets | 78 | 6 | 6 | — | — | |
| Total assets | 1,532 | 1,055 | 196 | — | — | |
| Accounts payable | 42 | 27 | 6 | — | — | |
| Accrued expenses and other current liabilities | 91 | 60 | 29 | — | — | |
| Total current liabilities | 133 | 87 | 35 | — | — | |
| Other liabilities | 35 | 3 | 4 | — | — | |
| Total liabilities | 168 | 90 | 39 | — | — | |
| Commitments and contingencies (Note 8) | — | — | — | — | — | |
| Common stock, $0.0001 par value; 1,000,000 shares authorized as of December 31, 2025 and 2024, respectively; 170,186 and 162,018 shares issued and outstanding as of December 31, 2025 and 2024, respectively | 17,000 | 16,000 | 4,000 | — | — | |
| Additional paid-in capital | 1,349 | 1,173 | 27 | — | — | |
| Accumulated other comprehensive income | 4 | 426,000 | 259,000 | — | — | |
| Retained earnings (accumulated deficit) | 10 | −209 | −125 | — | — | |
| Total stockholders equity | 1,364 | 965 | −98 | −85 | −40 | |
| Total liabilities and stockholders equity | 1,532 | 1,055 | 196 | — | — |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 |
|---|---|---|---|---|---|
| Stock-based compensation | 160 | 235 | 11 | 30 | |
| Depreciation and amortization | 7 | 3 | 2 | — | |
| Non-cash operating lease expense | 3 | 2 | 1 | 1 | |
| Warrants contra revenue | 6 | 1 | 805,000 | 343,000 | |
| Accretion of discounts on marketable securities | −8 | −8 | −2 | −525,000 | |
| Other | −1 | 263,000 | 10 | — | |
| Accounts receivable, net | −44 | −30 | 2 | −6 | |
| Inventory | −13 | −19 | −6 | −19 | |
| Prepaid expenses and other assets | −34 | −13 | −720,000 | −1 | |
| Accounts payable | 14 | 21 | −4 | 2 | |
| Accrued expenses and other liabilities | 16 | 31 | −167,000 | 16 | |
| Operating lease liability | −5 | −2 | −1 | −1 | |
| Net cash provided by (used in) operating activities | 319 | 137 | −13 | −36 | |
| Purchases of property and equipment | −38 | −34 | −3 | −4 | |
| Purchases of marketable securities | −858 | −931 | −126 | −89 | |
| Sales and maturities of marketable securities | 683 | 209 | 111 | 2 | |
| Payments for business combinations, net of cash acquired | −29 | 0 | 0 | — | |
| Other investment activities | −500,000 | −1 | 0 | 0 | |
| Net cash used in investing activities | −241 | −758 | −18 | −91 | |
| Proceeds from issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions | 0 | 672 | 0 | 0 | |
| Payment of deferred offering costs | 0 | −5 | −1 | 0 | |
| Proceeds from exercises of stock options | 2 | 5 | 1 | 2 | |
| Proceeds from employee stock purchase plan | 8 | 4 | 0 | 0 | |
| Tax withholding related to net share settlements of restricted stock units | 0 | −20 | 0 | 0 | |
| Repurchase of common stock upon termination | 0 | −1 | −210,000 | −313,000 | |
| Net cash provided by (used in) financing activities | 10 | 656 | −502,000 | 152 | |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 88 | 35 | −31 | 25 |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is Astera Labs, Inc.'s CIK number?
Astera Labs, Inc.'s SEC CIK number is 0001736297 (1736297). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find Astera Labs, Inc.'s SEC filings?
All of Astera Labs, Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did Astera Labs, Inc. last report earnings?
Astera Labs, Inc. (ALAB) most recently filed an earnings 8-K with the SEC on May 5, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001736297-26-000017). This is Astera Labs, Inc.'s most recent earnings filing of record — not a forecast of its next earnings date.
What is Astera Labs, Inc.'s most recent earnings 8-K?
Astera Labs, Inc.'s latest earnings 8-K (Item 2.02) was filed May 5, 2026 under accession 0001736297-26-000017. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View Astera Labs, Inc.'s latest earnings 8-K →
Look up any company's CIK number →